Alivus Life Sciences Limited has informed the Exchange about Schedule of meet
ALIVUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alivus Life Sciences Limited has informed the stock exchanges about a scheduled investor/analyst meeting under SEBI's Regulation 30 disclosure rules. The company will hold a one-on-one virtual meeting with Aberdeen, a global asset manager, on June 12, 2025. This is a routine compliance filing to keep the exchanges and public informed of its investor engagement activities. The company noted that the schedule and mode of the meeting may change due to unforeseen circumstances on either side.
This is a routine regulatory disclosure and is unlikely to have any direct impact on the stock price. However, a one-on-one meeting with a large global investor like Aberdeen signals continued institutional interest in the company, which can be viewed positively by retail investors.